Showing results (241-250 of 472) with videos related to
Sort By:
Pageof 48
International Journal of Immunopharmacology|January 1, 1991
Modulation of allogenic reaction by ticlopidine treatmentL Degos, J F Bourges, A Bensussan, et al.Human Immunology|March 1, 1990
Nucleotide sequence of the HLA-A26 class I gene: identification of specific residues and molecular mapping of public HLA class I epitopesH Zinszner, M Masset, J F Bourge, et al.The Journal of Experimental Medicine|April 1, 1987
Human T cell gamma genes are frequently rearranged in B-lineage acute lymphoblastic leukemias but not in chronic B cell proliferationsZ Chen, D Le Paslier, J Dausset, et al.Tissue Antigens|February 1, 1994
HLA-DRB1, DQA1 and DQB1 DNA polymorphisms in healthy Algerian and genetic relationships with other populationsS Djoulah, A Sanchez-Mazas, I Khalil, et al.Nouvelle Revue Francaise D'Hematologie|January 1, 1990
In vitro effects of retinoic acidC Chomienne, P Ballerini, M Huang, et al.Blood|November 1, 1990
All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical resultsS Castaigne, C Chomienne, M T Daniel, et al.Nouvelle Revue Francaise D'Hematologie|January 1, 1982
[Hematological toxicity of ticlopidine? (author's transl)]A de Gramont, C Canuel, M Krulik, et al.Blood|November 1, 1990
All-trans retinoic acid in acute promyelocytic leukemias. II. In vitro studies: structure-function relationshipC Chomienne, P Ballerini, N Balitrand, et al.Tissue Antigens|February 1, 1975
Combined analysis of three studies of patients with Burkitt's lymphomaJ G Bodmer, W F Bodmer, P Pickbourne, et al.Cancer|April 15, 1985
Low-dose cytosine arabinoside treatment for acute nonlymphocytic leukemia in elderly patientsH Tilly, S Castaigne, D Bordessoule, et al.Pageof 48